Orciprenaline


w242



General information:


Withdrawn ID: w242
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): R03AB03
R03CB03
R03CB53
Molecular Formula: C11H17NO3
Molweight: 211.258



Withdrawal information:


Withdrawn due to drug safety reasons:Yes
First approved: 2003
First withdrawn: 2009
Last withdrawn: 2009
Reference: https://www.ncbi.nlm.nih.gov/pubmed/23920058



Side-effects:

Total reported cases (submitted by medical professionals) with Orciprenaline as primary suspect: 10


Reported final outcomes:
Hospitalization (initial or prolonged): 5
Life-Threatening condition: 3
Disability: 1
Intervention required to prevent permanent impairment/damage: 1


Reported side-effects:

Side-effect Case number
ATRIAL FIBRILLATION1
HYPERHIDROSIS1
FEBRILE NEUTROPENIA1
DYSPNOEA1
DRUG INTERACTION1
DIARRHOEA1
DEPRESSION1
CIRCULATORY COLLAPSE1
CHEST PAIN1
BONE PAIN1
HYPOKINESIA1
ASTHENIA1
ARRHYTHMIA SUPRAVENTRICULAR1
ANTICONVULSANT DRUG LEVEL INCREASED1
ALCOHOL ABUSE1
Adverse drug reaction1
ACUTE MYOCARDIAL INFARCTION1
ABORTION INDUCED1
ABDOMINAL PAIN1
PALPITATIONS1
UTERINE CONTRACTIONS DURING PREGNANCY1
TREMOR1
SUICIDAL IDEATION1
STRESS CARDIOMYOPATHY1
RASH MACULO-PAPULAR1
PULMONARY OEDEMA1
Product name confusion1
PNEUMONIA1
PARAESTHESIA1
Wrong drug1
OVERDOSE1
NEUTROPENIC SEPSIS1
MUCOSAL INFLAMMATION1
LUNG CONSOLIDATION1
LIP SWELLING1
Intercepted product prescribing error1
INFECTION1
HYPOTENSION1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
P07550 501.19 Beta-2 adrenergic receptor ADRB2_HUMAN



Toxicity information:

Toxicity class: 5
Toxicity type: cardiovascular
LD50: 3370 mg/kg



External links:

ChEBML: CHEMBL776
DrugBank: DB00816